Studies on biomarkers in cancer etiology and prevention: a summary and challenge of 20 years of interdisciplinary research

被引:48
作者
Bartsch, H [1 ]
机构
[1] German Canc Res Ctr, DKFZ, Div Toxicol & Canc Risk Factors, D-69120 Heidelberg, Germany
关键词
biomarkers; cancer etiology; prevention; molecular epidemiology;
D O I
10.1016/S1383-5742(00)00008-9
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Sensitive, specific methods have been developed that allow quantitative measurements of the metabolites of carcinogen metabolites and of DNA and protein adducts in humans exposed occupationally, environmentally and endogenously to genotoxic agents. The interrelationship between exposure to carcinogens, host risk factors and the responses of biomarkers has been examined in cross-sectional, ecological and case-control studies which provided new insights into the causes of cancer and the mechanisms of carcinogenesis. The identification of hitherto unknown DNA-reactive chemicals formed in the human body from dietary precursors and of carcinogenic components of complex mixtures has increased the possibility of establishing causal relationships in etiology. The identification of individuals and subgroups heavily exposed to carcinogens has led to the development of measures for avoiding or decreasing exposure to carcinogenic risk factors. New, ultrasensitive methods for measuring DNA adducts allow the quantification and structural elucidation of specific DNA damage in humans arising from oxidative stress and lipid peroxidation (LPO), which have been found to be the driving forces in several human malignancies. Background DNA damage in "unexposed" individuals has been shown unequivocally to be due to LPO products, and a significant interindividual variation in adduct levels has been shown in individuals with comparable exposure to carcinogens. Thus, pharmacogenetic variants with higher susceptibility to carcinogenic insults, due to genetic polymorphism in xenobiotic-metabolizing enzymes, have been characterized by a combination of genotyping and measurements of macromolecular adducts. Dosimetry has been used in human studies to evaluate the efficacy of interventions with chemopreventive agents like ascorbic acid, dietary phenols and green tea. Advances in the application of selected biomarkers in human studies are reviewed and illustrated by examples from the author's research conducted during the past two decades. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:255 / 279
页数:25
相关论文
共 105 条
  • [1] Evidence of anti-benzo[a]pyrene diolepoxide-DNA adduct formation in human colon mucosa
    Alexandrov, K
    Rojas, M
    Kadlubar, FF
    Lang, NP
    Bartsch, H
    [J]. CARCINOGENESIS, 1996, 17 (09) : 2081 - 2083
  • [2] ALEXANDROV K, 1992, CANCER RES, V52, P6248
  • [3] [Anonymous], IARC SCI PUBL
  • [4] IMMUNOHISTOCHEMICAL DETECTION OF PULMONARY CYTOCHROME P450IA AND METABOLIC-ACTIVITIES ASSOCIATED WITH P450IA1 AND P450IA2 ISOZYMES IN LUNG-CANCER PATIENTS
    ANTTILA, S
    VAINIO, H
    HIETANEN, E
    CAMUS, AM
    MALAVEILLE, C
    BRUN, G
    HUSGAFVELPURSIAINEN, K
    HEIKKILA, L
    KARJALAINEN, A
    BARTSCH, H
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1992, 98 : 179 - 182
  • [5] SMOKING AND PERIPHERAL TYPE OF CANCER ARE RELATED TO HIGH-LEVELS OF PULMONARY CYTOCHROME-P450IA IN LUNG-CANCER PATIENTS
    ANTTILA, S
    HIETANEN, E
    VAINIO, H
    CAMUS, AM
    GELBOIN, HV
    PARK, SS
    HEIKKILA, L
    KARJALAINEN, A
    BARTSCH, H
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (05) : 681 - 685
  • [6] BARTECH H, 1993, ENV HLTH PERSPECT, V99, P1
  • [7] INHIBITORS OF ENDOGENOUS NITROSATION - MECHANISMS AND IMPLICATIONS IN HUMAN CANCER PREVENTION
    BARTSCH, H
    OHSHIMA, H
    PIGNATELLI, B
    [J]. MUTATION RESEARCH, 1988, 202 (02): : 307 - 324
  • [8] DNA adducts in human carcinogenesis: Etiological relevance and structure-activity relationship
    Bartsch, H
    [J]. MUTATION RESEARCH-REVIEWS IN GENETIC TOXICOLOGY, 1996, 340 (2-3): : 67 - 79
  • [9] CARCINOGEN HEMOGLOBIN ADDUCTS, URINARY MUTAGENICITY, AND METABOLIC PHENOTYPE IN ACTIVE AND PASSIVE CIGARETTE SMOKERS
    BARTSCH, H
    CAPORASO, N
    CODA, M
    KADLUBAR, F
    MALAVEILLE, C
    SKIPPER, P
    TALASKA, G
    TANNENBAUM, SR
    VINEIS, P
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (23): : 1826 - 1831
  • [10] Bartsch H, 1996, IARC SCI PUBL, P189